Table 2.
Baseline characteristics of the three patients' groups.
| CB-SMA (n = 11) | CB-M1 (n = 11) | CB-single (n = 9) | P-value | |
|---|---|---|---|---|
| Age (years) | 50.36 ± 8.99 | 47.18 ± 11.98 | 54.44 ± 14.21 | 0.400a |
| Gender (male/female) | 10/1 | 10/1 | 8/1 | 0.985b |
| Course of stroke (days) | 50.00 (13.00) | 50.00 (17.00) | 49.00 (25.00) | 0.861c |
| FMA-LE | 23.45 ± 4.72 | 22.64 ± 6.76 | 23.44 ± 5.08 | 0.929a |
| BBS | 43.00 ± 11.58 | 35.45 ± 12.08 | 41.56 ± 12.25 | 0.311a |
| Education (years) | 12.00 ± 7.00 | 16 ± 7.00 | 12.00 ± 9.00 | 0.708c |
| Primary diagnosis | 0.878b | |||
| Hemorrhagic | 5 (45.6%) | 6 (54.5%) | 4 (44.4%) | |
| Ischemic | 6 (54.5%) | 5 (45.5%) | 5 (55.6%) | |
| Paralysis side | 0.878b | |||
| Right | 5 (45.5%) | 6 (54.5%) | 5 (55.6%) | |
| Left | 6 (54.5%) | 5 (45.5%) | 4 (44.4%) |
Data are expressed as Mean ± SD, N (%), or Mid (IQR).
aOne-way ANOVA;
bChi–square test;
cKruskal–Wallis test.